Ep178: Peyton Greenside on ML-Guided Biologics Discovery episode artwork

EPISODE · May 13, 2025 · 1H 2M

Ep178: Peyton Greenside on ML-Guided Biologics Discovery

from The Long Run with Luke Timmerman · host Timmerman Report

Peyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.

Peyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.

NOW PLAYING

Ep178: Peyton Greenside on ML-Guided Biologics Discovery

0:00 1:02:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 2 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on May 13, 2025.

What is this episode about?

Peyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!